Kelly David George 4
4 · Iterum Therapeutics plc · Filed May 30, 2018
Insider Transaction Report
Form 4
Kelly David George
Director
Transactions
- Conversion
Ordinary Shares
2018-05-30+9,548→ 9,548 total - Conversion
Series A Preferred Shares
2018-05-30−9,548→ 0 total→ Ordinary Shares (9,548 underlying)
Footnotes (2)
- [F1]The Series A Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer.
- [F2]Not applicable.